Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial.

Ferreira RS, D'Ancona CAL, Oelke M, Carneiro MR.

Einstein (Sao Paulo). 2018 Aug 6;16(3):eAO4207. doi: 10.1590/S1679-45082018AO4207. English, Portuguese.

2.

The application of W-plasty combined Botox-A injection in treating sunk scar on the face.

Chen H, Pan W, Zhang J, Cheng H, Tan Q.

Medicine (Baltimore). 2018 Jul;97(30):e11427. doi: 10.1097/MD.0000000000011427.

3.

Botulinum toxin injection and tear production.

Alsuhaibani AH, Eid SA.

Curr Opin Ophthalmol. 2018 Sep;29(5):428-433. doi: 10.1097/ICU.0000000000000506. Review.

PMID:
29994851
4.

Botulinum toxins for the prevention of migraine in adults.

Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives N, Clarke CE, Sinclair A.

Cochrane Database Syst Rev. 2018 Jun 25;6:CD011616. doi: 10.1002/14651858.CD011616.pub2. Review.

PMID:
29939406
5.

Duration of effectiveness of Botulinum toxin type A in excessive gingival display: a systematic review and meta-analysis.

Chagas TF, Almeida NV, Lisboa CO, Ferreira DMTP, Mattos CT, Mucha JN.

Braz Oral Res. 2018;32:e30. doi: 10.1590/1807-3107bor-2018.vol32.0030. Epub 2018 May 7. Review.

6.

Effect of therapeutic exercise on knee osteoarthritis after intra-articular injection of botulinum toxin type A, hyaluronate or saline: A randomized controlled trial.

Bao X, Tan JW, Flyzik M, Ma XC, Liu H, Liu HY.

J Rehabil Med. 2018 Jun 15;50(6):534-541. doi: 10.2340/16501977-2340.

7.

Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study.

Lueangarun S, Sermsilp C, Tempark T.

Dermatol Surg. 2018 Aug;44(8):1094-1101. doi: 10.1097/DSS.0000000000001532.

PMID:
29659406
8.

Modern management of esophageal achalasia: From pathophysiology to treatment.

Schlottmann F, Herbella F, Allaix ME, Patti MG.

Curr Probl Surg. 2018 Jan;55(1):10-37. doi: 10.1067/j.cpsurg.2018.01.001. Epub 2018 Jan 31. Review. No abstract available.

PMID:
29548347
9.

Attention to Infection Prevention in Medical Aesthetic Clinics.

Hotta TA.

Plast Surg Nurs. 2018 Jan/Mar;38(1):17-24. doi: 10.1097/PSN.0000000000000215.

PMID:
29494408
10.

Effects of Botulinum Toxin on Improving Facial Surgical Scars: A Prospective, Split-Scar, Double-Blind, Randomized Controlled Trial.

Hu L, Zou Y, Chang SJ, Qiu Y, Chen H, Gang M, Jin Y, Lin X.

Plast Reconstr Surg. 2018 Mar;141(3):646-650. doi: 10.1097/PRS.0000000000004110.

PMID:
29481395
11.

Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials.

Sridharan K, Sivaramakrishnan G.

J Clin Neurosci. 2018 May;51:12-17. doi: 10.1016/j.jocn.2018.02.011. Epub 2018 Feb 21. Review.

PMID:
29475576
12.

Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A.

Tiigimäe-Saar J, Tamme T, Rosenthal M, Kadastik-Eerme L, Taba P.

Neurol Sci. 2018 May;39(5):871-877. doi: 10.1007/s10072-018-3279-4. Epub 2018 Feb 19.

PMID:
29460161
13.

Botulinum toxin: A review of the mode of action in migraine.

Do TP, Hvedstrup J, Schytz HW.

Acta Neurol Scand. 2018 May;137(5):442-451. doi: 10.1111/ane.12906. Epub 2018 Feb 6. Review.

PMID:
29405250
14.

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.

Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A.

J Headache Pain. 2018 Feb 5;19(1):13. doi: 10.1186/s10194-018-0840-8.

15.

The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.

Austin E, Koo E, Jagdeo J.

Dermatol Surg. 2018 Feb;44(2):149-157. doi: 10.1097/DSS.0000000000001360. Review.

PMID:
29401161
16.

Paradoxical Frontalis Activation: An Underrecognized Consequence of Facial Palsy.

Cooper L, Izard C, Harries V, Neville C, Venables V, Malhotra R, Nduka C.

Plast Reconstr Surg. 2018 Feb;141(2):263e-270e. doi: 10.1097/PRS.0000000000004057.

PMID:
29369999
17.

A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia.

Lew MF, Brashear A, Dashtipour K, Isaacson S, Hauser RA, Maisonobe P, Snyder D, Ondo W.

Int J Neurosci. 2018 Jul;128(7):619-626. doi: 10.1080/00207454.2017.1406935. Epub 2018 Jan 17.

PMID:
29343142
18.

Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).

Meng E, Hsu YC, Chuang YC.

Low Urin Tract Symptoms. 2018 Jan;10(1):3-11. doi: 10.1111/luts.12214. Review.

PMID:
29341502
19.

A Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments.

Dayan SH, Ho TT, Bacos JT, Gandhi ND, Kalbag A, Gutierrez-Borst S.

J Drugs Dermatol. 2018 Jan 1;17(1):48-54.

PMID:
29320587
20.

Botulinum toxin for motor and phonic tics in Tourette's syndrome.

Pandey S, Srivanitchapoom P, Kirubakaran R, Berman BD.

Cochrane Database Syst Rev. 2018 Jan 5;1:CD012285. doi: 10.1002/14651858.CD012285.pub2. Review.

PMID:
29304272

Supplemental Content

Loading ...
Support Center